Researchers at the University of Colorado Anschutz Medical Campus observed unusual changes in brain connectivity while ...

Ozempic was supposed to be a gut story. Then Allison Shapiro looked at the brain scans. An assistant professor at the ...

GLP-1 receptor agonists, already used for Type 2 diabetes and obesity, show promise in reducing alcohol and drug-seeking ...

A new study shows oral GLP-1 drugs suppress hedonic eating through a deep-brain reward circuit linked to dopamine release, potentially extending their use beyond weight loss.

Because unpleasant withdrawal symptoms fuel nicotine addiction's high relapse rate, targeting their underlying mechanisms with treatments may promote continued abstinence from the drug. In a new ...

The session explored how long-term use of substances affects thinking, behaviour, and everyday decision-making and why ...

Researchers say an experimental Alzheimer's drug may calm brain inflammation linked to alcohol withdrawal, potentially ...

Can semaglutide reduce alcohol consumption? New research explores its role in alcohol use disorder and obesity.

For decades, my colleagues and I advanced the premise that early substance use—nicotine, alcohol, or cannabis (or other addicting drugs)—interferes with critical maturation stages, particularly ...